uniQure N.V. Made Big Gain
Wed, Sep 24, 2025 at 07:51 PM
uniQure N.V. (QURE:NASDAQ) shot up at $47.5, representing a gain of 247.7%. On Wed, Sep 24, 2025, QURE:NASDAQ hit a New 2-Week High of $47.5. The stock appeared on our News Catalysts scanner on Wed, Sep 24, 2025 at 04:58 PM in the 'BIOTECH' category. From Wed, Sep 10, 2025, the stock recorded 20.00% Up Days and 18.18% Green Days
About uniQure N.V. (QURE:NASDAQ)
uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Top 10 Gainers:
- uniQure N.V. (QURE:NASDAQ), 247.73%
- SHF Holdings, Inc. (SHFS:NASDAQ), 123.01%
- Smart for Life, Inc. (SMFL:NASDAQ), 100%
- Lithium Americas Corp. (LAC:NYSE), 95.77%
- RedCloud Holdings plc (RCT:NASDAQ), 64.71%
- ClearPoint Neuro, Inc. (CLPT:NASDAQ), 58.55%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 47.68%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 45.96%
- Aqua Metals, Inc. (AQMS:NASDAQ), 44.94%